In a double-blinded RCT by Faghihzadeh et al., 50 NAFLD patients were divided to receive lifestyle modification and placebo or 500 mg of resveratrol for 12 weeks and after the study period the treatment group had improved inflammatory cytokines, ALT, and hepatic steatosis compared to the placebo group [27,29]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.